Articles from Claritas Rx

Claritas Rx, the patient journey experts, announced the availability of a new white paper entitled “Quantifying Connection: Measuring Partner Impact and CRM ROI Across the Enterprise.” The paper reveals that an omnichannel CRM, purpose-built for Patient Services teams and their partners (SPs, hubs) can reduce overall time to fill, increase fill rates and drive more patient-months on therapy with greater treatment value.

Claritas Rx, the patient journey experts, announced the availability of AI-powered Performance Benchmarking. The service turns comprehensive specialty data into a real-time view of how brands compare against their competitors. Market Alerts enable brands to respond faster to competitor shifts—such as identifying when patients discontinue a competitor’s therapy—allowing for timely engagement with prescribers. Performance Benchmarking offers the first and only real-world data set that quantifies key market access metrics often invisible in claims, including fill rates, time to fill, discontinuation dates and reasons, and more, across specialty brands.

Claritas Rx, the patient journey experts, announced the availability of Access Analytics that delivers real-time channel and competitive visibility into brand performance by reducing the data lags that plague traditional reporting methods. Access Analytics equips Market Access teams with transparency across the treatment continuum, enabling them to respond swiftly and efficiently to emerging needs, evaluate program effectiveness and optimize patient services.

Claritas Rx, the leader in intelligent solutions that provide real-time visibility across the entire patient journey, announced today it has been named to the prestigious Inc. 5000 list, the most respected ranking of the fastest-growing private companies in America. The list provides a data-driven snapshot of the most successful companies within the economy’s most dynamic segment—its independent, entrepreneurial businesses. Past honorees include companies such as Microsoft, Meta, Chobani, Under Armour, Timberland, Oracle and Patagonia.

Claritas Rx, the leader in technology and analytics to optimize the specialty patient experience, announces the availability of its new white paper entitled “From Prescription to Abandonment: How 31% of Specialty Medications Go Unfilled Across Therapeutic Areas.” The new thought piece explores patient abandonment during pharmacy transitions and contributing factors of abandonment including administrative complexity, communications failures, insurance and cost concerns, and patient burden.

Claritas Rx, the leader in technology and analytics to optimize the specialty patient experience, is proud to announce it has been named to Inc.’s 2025 Best Workplaces list, honoring companies that have built exceptional workplaces and vibrant cultures that support their teams and businesses.

Claritas Rx, the leader in technology and analytics to optimize the specialty patient experience, announced new leadership appointments designed to continue growth and scale. The company has welcomed Kevin Donalds as Chief Financial Officer (CFO) and Elizabeth Marshall as Head of Marketing. Both will report directly to Michael Fitzgibbons, Claritas Rx’s CEO.

ASEMBIA AXS25 – Claritas Rx, the leader in technology and analytics to optimize the specialty patient experience, announced today the availability of Patient Watchtower, the first and only care coordination platform for specialty and rare disease patients. SaaS-based Patient Watchtower seamlessly merges complex and fragmented patient data from various sources and creates immediate actionable insights. It uses artificial intelligence and machine learning (AIML) to enable precise patient microtargeting based on risk factors, ensuring the patient will receive prompt treatment.